Search research articles
Contact Us
Filters
Showing results (761-770 of 774) with videos related to
Page
of 78
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations
Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Neuro-Oncology
|
June 2, 2022
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
Santhosh A Upadhyaya, Olivia Campagne, Catherine A Billups, et al.
The Oncologist
|
September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
Adrienne Johnson, Eric Severson, Laurie Gay, et al.
Nature Communications
|
February 14, 2019
Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy
Jennifer Friedman, Desiree E Smith, Mahmoud Y Issa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2021
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
Santhosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
The Lancet. Oncology
|
May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Giles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Acta Neuropathologica
|
August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials
Anthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Cancer Research
|
October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma
Jessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Nature Neuroscience
|
May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
Alexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Genetics
|
November 9, 2023
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma
Owen S Chapman, Jens Luebeck, Sunita Sridhar, et al.
Page
of 78
Search research articles
Search
Showing results (761-770 of 774) with videos related to
Sort By:
Page
of 78
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations
Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Neuro-Oncology
|
June 2, 2022
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
Santhosh A Upadhyaya, Olivia Campagne, Catherine A Billups, et al.
The Oncologist
|
September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
Adrienne Johnson, Eric Severson, Laurie Gay, et al.
Nature Communications
|
February 14, 2019
Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy
Jennifer Friedman, Desiree E Smith, Mahmoud Y Issa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2021
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
Santhosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
The Lancet. Oncology
|
May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Giles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Acta Neuropathologica
|
August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials
Anthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Cancer Research
|
October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma
Jessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Nature Neuroscience
|
May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
Alexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Genetics
|
November 9, 2023
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma
Owen S Chapman, Jens Luebeck, Sunita Sridhar, et al.
Page
of 78